Service & Software

Global Immuno-Oncology Service Market Research Report 2026

This report delivers a comprehensive overview of the global Immuno-Oncology Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immuno-Oncology Service. The Immuno-Oncology Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Immuno-Oncology Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Immuno-Oncology Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Crown Bioscience
Bio-Techne
Abcam
WuXi AppTec
Shanghai ChemPartner
George Clinical
Laboratory Corporation of America® Holdings
Medpace
Genscript
Shanghai Novamab Biopharmaceuticals
LIDE
TransCure bioServices
Segment by Type
Basic Research
Clinical Research
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Immuno-Oncology Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Oncology Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Basic Research
1.2.3 Clinical Research
1.3 Market by Application
1.3.1 Global Immuno-Oncology Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Service Market Perspective (2021–2032)
2.2 Global Immuno-Oncology Service Growth Trends by Region
2.2.1 Global Immuno-Oncology Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Immuno-Oncology Service Historic Market Size by Region (2021–2026)
2.2.3 Immuno-Oncology Service Forecasted Market Size by Region (2027–2032)
2.3 Immuno-Oncology Service Market Dynamics
2.3.1 Immuno-Oncology Service Industry Trends
2.3.2 Immuno-Oncology Service Market Drivers
2.3.3 Immuno-Oncology Service Market Challenges
2.3.4 Immuno-Oncology Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Service Players by Revenue
3.1.1 Global Top Immuno-Oncology Service Players by Revenue (2021–2026)
3.1.2 Global Immuno-Oncology Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Immuno-Oncology Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Immuno-Oncology Service Revenue
3.4 Global Immuno-Oncology Service Market Concentration Ratio
3.4.1 Global Immuno-Oncology Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Service Revenue in 2025
3.5 Global Key Players of Immuno-Oncology Service Head Offices and Areas Served
3.6 Global Key Players of Immuno-Oncology Service, Products and Applications
3.7 Global Key Players of Immuno-Oncology Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Immuno-Oncology Service Breakdown Data by Type
4.1 Global Immuno-Oncology Service Historic Market Size by Type (2021–2026)
4.2 Global Immuno-Oncology Service Forecasted Market Size by Type (2027–2032)
5 Immuno-Oncology Service Breakdown Data by Application
5.1 Global Immuno-Oncology Service Historic Market Size by Application (2021–2026)
5.2 Global Immuno-Oncology Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Immuno-Oncology Service Market Size (2021–2032)
6.2 North America Immuno-Oncology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Immuno-Oncology Service Market Size by Country (2021–2026)
6.4 North America Immuno-Oncology Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno-Oncology Service Market Size (2021–2032)
7.2 Europe Immuno-Oncology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Immuno-Oncology Service Market Size by Country (2021–2026)
7.4 Europe Immuno-Oncology Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Oncology Service Market Size (2021–2032)
8.2 Asia-Pacific Immuno-Oncology Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Immuno-Oncology Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Immuno-Oncology Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Immuno-Oncology Service Market Size (2021–2032)
9.2 Latin America Immuno-Oncology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Immuno-Oncology Service Market Size by Country (2021–2026)
9.4 Latin America Immuno-Oncology Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Oncology Service Market Size (2021–2032)
10.2 Middle East & Africa Immuno-Oncology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Immuno-Oncology Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Immuno-Oncology Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Immuno-Oncology Service Introduction
11.1.4 Crown Bioscience Revenue in Immuno-Oncology Service Business (2021–2026)
11.1.5 Crown Bioscience Recent Development
11.2 Bio-Techne
11.2.1 Bio-Techne Company Details
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Immuno-Oncology Service Introduction
11.2.4 Bio-Techne Revenue in Immuno-Oncology Service Business (2021–2026)
11.2.5 Bio-Techne Recent Development
11.3 Abcam
11.3.1 Abcam Company Details
11.3.2 Abcam Business Overview
11.3.3 Abcam Immuno-Oncology Service Introduction
11.3.4 Abcam Revenue in Immuno-Oncology Service Business (2021–2026)
11.3.5 Abcam Recent Development
11.4 WuXi AppTec
11.4.1 WuXi AppTec Company Details
11.4.2 WuXi AppTec Business Overview
11.4.3 WuXi AppTec Immuno-Oncology Service Introduction
11.4.4 WuXi AppTec Revenue in Immuno-Oncology Service Business (2021–2026)
11.4.5 WuXi AppTec Recent Development
11.5 Shanghai ChemPartner
11.5.1 Shanghai ChemPartner Company Details
11.5.2 Shanghai ChemPartner Business Overview
11.5.3 Shanghai ChemPartner Immuno-Oncology Service Introduction
11.5.4 Shanghai ChemPartner Revenue in Immuno-Oncology Service Business (2021–2026)
11.5.5 Shanghai ChemPartner Recent Development
11.6 George Clinical
11.6.1 George Clinical Company Details
11.6.2 George Clinical Business Overview
11.6.3 George Clinical Immuno-Oncology Service Introduction
11.6.4 George Clinical Revenue in Immuno-Oncology Service Business (2021–2026)
11.6.5 George Clinical Recent Development
11.7 Laboratory Corporation of America® Holdings
11.7.1 Laboratory Corporation of America® Holdings Company Details
11.7.2 Laboratory Corporation of America® Holdings Business Overview
11.7.3 Laboratory Corporation of America® Holdings Immuno-Oncology Service Introduction
11.7.4 Laboratory Corporation of America® Holdings Revenue in Immuno-Oncology Service Business (2021–2026)
11.7.5 Laboratory Corporation of America® Holdings Recent Development
11.8 Medpace
11.8.1 Medpace Company Details
11.8.2 Medpace Business Overview
11.8.3 Medpace Immuno-Oncology Service Introduction
11.8.4 Medpace Revenue in Immuno-Oncology Service Business (2021–2026)
11.8.5 Medpace Recent Development
11.9 Genscript
11.9.1 Genscript Company Details
11.9.2 Genscript Business Overview
11.9.3 Genscript Immuno-Oncology Service Introduction
11.9.4 Genscript Revenue in Immuno-Oncology Service Business (2021–2026)
11.9.5 Genscript Recent Development
11.10 Shanghai Novamab Biopharmaceuticals
11.10.1 Shanghai Novamab Biopharmaceuticals Company Details
11.10.2 Shanghai Novamab Biopharmaceuticals Business Overview
11.10.3 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Introduction
11.10.4 Shanghai Novamab Biopharmaceuticals Revenue in Immuno-Oncology Service Business (2021–2026)
11.10.5 Shanghai Novamab Biopharmaceuticals Recent Development
11.11 LIDE
11.11.1 LIDE Company Details
11.11.2 LIDE Business Overview
11.11.3 LIDE Immuno-Oncology Service Introduction
11.11.4 LIDE Revenue in Immuno-Oncology Service Business (2021–2026)
11.11.5 LIDE Recent Development
11.12 TransCure bioServices
11.12.1 TransCure bioServices Company Details
11.12.2 TransCure bioServices Business Overview
11.12.3 TransCure bioServices Immuno-Oncology Service Introduction
11.12.4 TransCure bioServices Revenue in Immuno-Oncology Service Business (2021–2026)
11.12.5 TransCure bioServices Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Immuno-Oncology Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Basic Research
Table 3. Key Players of Clinical Research
Table 4. Global Immuno-Oncology Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Immuno-Oncology Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Immuno-Oncology Service Market Size by Region (US$ Million), 2021–2026
Table 7. Global Immuno-Oncology Service Market Share by Region (2021–2026)
Table 8. Global Immuno-Oncology Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Immuno-Oncology Service Market Share by Region (2027–2032)
Table 10. Immuno-Oncology Service Market Trends
Table 11. Immuno-Oncology Service Market Drivers
Table 12. Immuno-Oncology Service Market Challenges
Table 13. Immuno-Oncology Service Market Restraints
Table 14. Global Immuno-Oncology Service Revenue by Players (US$ Million), 2021–2026
Table 15. Global Immuno-Oncology Service Market Share by Players (2021–2026)
Table 16. Global Top Immuno-Oncology Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Immuno-Oncology Service Revenue, 2025
Table 17. Ranking of Global Top Immuno-Oncology Service Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Immuno-Oncology Service Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Immuno-Oncology Service, Headquarters and Area Served
Table 20. Global Key Players of Immuno-Oncology Service, Products and Applications
Table 21. Global Key Players of Immuno-Oncology Service, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Immuno-Oncology Service Market Size by Type (US$ Million), 2021–2026
Table 24. Global Immuno-Oncology Service Revenue Market Share by Type (2021–2026)
Table 25. Global Immuno-Oncology Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Immuno-Oncology Service Revenue Market Share by Type (2027–2032)
Table 27. Global Immuno-Oncology Service Market Size by Application (US$ Million), 2021–2026
Table 28. Global Immuno-Oncology Service Revenue Market Share by Application (2021–2026)
Table 29. Global Immuno-Oncology Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Immuno-Oncology Service Revenue Market Share by Application (2027–2032)
Table 31. North America Immuno-Oncology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Immuno-Oncology Service Market Size by Country (US$ Million), 2021–2026
Table 33. North America Immuno-Oncology Service Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Immuno-Oncology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Immuno-Oncology Service Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Immuno-Oncology Service Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Immuno-Oncology Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Immuno-Oncology Service Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Immuno-Oncology Service Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Immuno-Oncology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Immuno-Oncology Service Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Immuno-Oncology Service Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Immuno-Oncology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Immuno-Oncology Service Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Immuno-Oncology Service Market Size by Country (US$ Million), 2027–2032
Table 46. Crown Bioscience Company Details
Table 47. Crown Bioscience Business Overview
Table 48. Crown Bioscience Immuno-Oncology Service Product
Table 49. Crown Bioscience Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 50. Crown Bioscience Recent Development
Table 51. Bio-Techne Company Details
Table 52. Bio-Techne Business Overview
Table 53. Bio-Techne Immuno-Oncology Service Product
Table 54. Bio-Techne Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 55. Bio-Techne Recent Development
Table 56. Abcam Company Details
Table 57. Abcam Business Overview
Table 58. Abcam Immuno-Oncology Service Product
Table 59. Abcam Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 60. Abcam Recent Development
Table 61. WuXi AppTec Company Details
Table 62. WuXi AppTec Business Overview
Table 63. WuXi AppTec Immuno-Oncology Service Product
Table 64. WuXi AppTec Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 65. WuXi AppTec Recent Development
Table 66. Shanghai ChemPartner Company Details
Table 67. Shanghai ChemPartner Business Overview
Table 68. Shanghai ChemPartner Immuno-Oncology Service Product
Table 69. Shanghai ChemPartner Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 70. Shanghai ChemPartner Recent Development
Table 71. George Clinical Company Details
Table 72. George Clinical Business Overview
Table 73. George Clinical Immuno-Oncology Service Product
Table 74. George Clinical Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 75. George Clinical Recent Development
Table 76. Laboratory Corporation of America® Holdings Company Details
Table 77. Laboratory Corporation of America® Holdings Business Overview
Table 78. Laboratory Corporation of America® Holdings Immuno-Oncology Service Product
Table 79. Laboratory Corporation of America® Holdings Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 80. Laboratory Corporation of America® Holdings Recent Development
Table 81. Medpace Company Details
Table 82. Medpace Business Overview
Table 83. Medpace Immuno-Oncology Service Product
Table 84. Medpace Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 85. Medpace Recent Development
Table 86. Genscript Company Details
Table 87. Genscript Business Overview
Table 88. Genscript Immuno-Oncology Service Product
Table 89. Genscript Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 90. Genscript Recent Development
Table 91. Shanghai Novamab Biopharmaceuticals Company Details
Table 92. Shanghai Novamab Biopharmaceuticals Business Overview
Table 93. Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Product
Table 94. Shanghai Novamab Biopharmaceuticals Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 95. Shanghai Novamab Biopharmaceuticals Recent Development
Table 96. LIDE Company Details
Table 97. LIDE Business Overview
Table 98. LIDE Immuno-Oncology Service Product
Table 99. LIDE Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 100. LIDE Recent Development
Table 101. TransCure bioServices Company Details
Table 102. TransCure bioServices Business Overview
Table 103. TransCure bioServices Immuno-Oncology Service Product
Table 104. TransCure bioServices Revenue in Immuno-Oncology Service Business (US$ Million), 2021–2026
Table 105. TransCure bioServices Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report


List of Figures
Figure 1. Immuno-Oncology Service Picture
Figure 2. Global Immuno-Oncology Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Immuno-Oncology Service Market Share by Type: 2025 vs 2032
Figure 4. Basic Research Features
Figure 5. Clinical Research Features
Figure 6. Global Immuno-Oncology Service Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Immuno-Oncology Service Market Share by Application: 2025 vs 2032
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Medical Device Companies Case Studies
Figure 10. Other Case Studies
Figure 11. Immuno-Oncology Service Report Years Considered
Figure 12. Global Immuno-Oncology Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Immuno-Oncology Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Immuno-Oncology Service Market Share by Region: 2025 vs 2032
Figure 15. Global Immuno-Oncology Service Market Share by Players in 2025
Figure 16. Global Immuno-Oncology Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Immuno-Oncology Service Revenue in 2025
Figure 18. North America Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Immuno-Oncology Service Market Share by Country (2021–2032)
Figure 20. United States Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Immuno-Oncology Service Market Share by Country (2021–2032)
Figure 24. Germany Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Immuno-Oncology Service Market Share by Region (2021–2032)
Figure 32. China Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Immuno-Oncology Service Market Share by Country (2021–2032)
Figure 40. Mexico Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Immuno-Oncology Service Market Share by Country (2021–2032)
Figure 44. Israel Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Immuno-Oncology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Crown Bioscience Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 48. Bio-Techne Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 49. Abcam Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 50. WuXi AppTec Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 51. Shanghai ChemPartner Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 52. George Clinical Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 53. Laboratory Corporation of America® Holdings Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 54. Medpace Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 55. Genscript Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 56. Shanghai Novamab Biopharmaceuticals Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 57. LIDE Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 58. TransCure bioServices Revenue Growth Rate in Immuno-Oncology Service Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies